Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Bethany Pappalardo

//Bethany Pappalardo

    Bethany Pappalardo was diagnosed with relapsing–remitting multiple sclerosis (RRMS) in 1998. At the age of 24, she could barely walk and was relapsing every three months. With no drug therapies available to her to combat the disease, she contacted Dr. Richard Burt at the Feinberg School of Medicine at Northwestern University regarding his work with stem cell therapy and autoimmune diseases focusing on multiple sclerosis. 

    Multiple sclerosis (MS) is an unpredictable and potentially disabling disease of the central nervous system that interrupts the flow of information within the brain and between the brain and the body. In MS, the patient’s immune system turns against the fatty layers of myelin that coat and protect neurons resulting in faulty transmissions of neural signals and symptoms ranging from weakness to hallucinations to cognitive decline. As the first major stage of MS, RMMS is characterized by flare–ups followed by periods of normal functioning. After 10 to 15 years of having RRMS, patients progress to the second stage called secondary progressive MS during which neurological decline and lack of muscle control become irreversible. 

    In early 2005, Bethany was accepted into Dr. Burt’s study, during which she received an autologous nonmyeloablative hematopoietic stem cell transplant. Bethany’s immune stem cells were harvested from her blood and low–dose chemotherapy was used to kill the majority of her white blood cells responsible for myelin attack. Bethany received her stem cell transplant on March 8, 2005. She was released from the hospital after 16 days and although her immune system was still compromised, she was getting stronger every day. She was able to go back to work part–time three and a half weeks after her transplant and by the beginning of April 2005, she resumed normal day–to–day activities. 

    Bethany has been in remission from MS since her transplant and calls her transplant date her second birthday. After nearly 13 years, Bethany continues to live a normal life with no signs of ever being sick. She is capable of living on her own and has a healthy life. She works as a jewelry buyer in Peoria, Illinois, and has been a tireless advocate of stem cell research and treatments.

    2018-04-20T12:13:27+00:00